Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.


Clinical Trial Description

Samples will be retained for possible analyses such as lactoferrin absorption, distribution, metabolism, and excretion (ADME) and gut microbiota. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06012669
Study type Interventional
Source Midwest Center for Metabolic and Cardiovascular Research
Contact
Status Completed
Phase N/A
Start date September 6, 2023
Completion date December 27, 2023

See also
  Status Clinical Trial Phase
Completed NCT05595980 - The Effects of a Novel Probiotic on Gastrointestinal Health in Generally Healthy Adults N/A
Recruiting NCT06067477 - Estimation of the Dietary Requirement for Vitamin D in Ethnic Groups N/A
Completed NCT04780867 - Psychological and Lifestyle Factors on Health Outcomes N/A
Active, not recruiting NCT05059639 - Exploring the Role of Almonds in Enhancing Immune Strength N/A
Completed NCT05004454 - Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults N/A
Completed NCT04733924 - Efficacy and Tolerability of Sensoril® in Improving Immunity and Thereby Reducing Incidence of Upper Respiratory Tract Infections N/A
Completed NCT04713735 - Impact of Lactoferrin, a Dietary Supplement, vs. Placebo on Respiratory Tract Infections N/A